A detailed history of Black Rock Inc. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,999,518 shares of OLMA stock, worth $35.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,999,518
Previous 3,216,554 24.34%
Holding current value
$35.6 Million
Previous $36.4 Million 18.85%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.73 - $13.99 $6.84 Million - $11 Million
782,964 Added 24.34%
3,999,518 $43.3 Million
Q1 2024

May 10, 2024

SELL
$10.95 - $16.62 $518,515 - $787,006
-47,353 Reduced 1.45%
3,216,554 $36.4 Million
Q4 2023

Feb 13, 2024

BUY
$10.53 - $17.14 $10.8 Million - $17.5 Million
1,021,018 Added 45.52%
3,263,907 $45.8 Million
Q3 2023

Nov 13, 2023

SELL
$8.19 - $12.98 $740,466 - $1.17 Million
-90,411 Reduced 3.87%
2,242,889 $27.7 Million
Q2 2023

Aug 11, 2023

BUY
$3.22 - $9.65 $4.31 Million - $12.9 Million
1,337,123 Added 134.23%
2,333,300 $21.1 Million
Q1 2023

May 12, 2023

SELL
$2.55 - $4.97 $119,895 - $233,679
-47,018 Reduced 4.51%
996,177 $3.46 Million
Q4 2022

Feb 13, 2023

SELL
$2.27 - $3.76 $587,319 - $972,828
-258,731 Reduced 19.87%
1,043,195 $2.56 Million
Q3 2022

Nov 14, 2022

SELL
$2.72 - $5.88 $9,732 - $21,038
-3,578 Reduced 0.27%
1,301,926 $3.59 Million
Q2 2022

Aug 12, 2022

SELL
$2.04 - $4.61 $2.54 Million - $5.75 Million
-1,247,445 Reduced 48.86%
1,305,504 $5.31 Million
Q1 2022

May 12, 2022

BUY
$3.89 - $9.43 $991,113 - $2.4 Million
254,785 Added 11.09%
2,552,949 $10.9 Million
Q4 2021

Feb 10, 2022

SELL
$8.75 - $30.71 $365,846 - $1.28 Million
-41,811 Reduced 1.79%
2,298,164 $21.5 Million
Q3 2021

Nov 09, 2021

BUY
$22.96 - $30.13 $20 Million - $26.2 Million
870,796 Added 59.27%
2,339,975 $64.5 Million
Q2 2021

Aug 11, 2021

BUY
$21.15 - $36.14 $31.1 Million - $53.1 Million
1,469,179 New
1,469,179 $41.1 Million

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $360M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.